Pacemakers Save Lives…
But beware of infection
Over two million Americans are alive today because of implantable electrical therapy devices such as pacemakers.1 Yet this common surgery is associated with a surgical site infection risk of up to 7%2—higher than the national average of 2% to 3%3—and can lead to severe health complications, extended hospital stays, and significantly increased medical costs. Heart device infection can be especially life threatening for these chronically ill patients.
The good news—heart device infection is preventable
Reducing the risk of surgical site infection from hospital superbugs such as MRSA is a top priority for hospitals everywhere, and many preventative measures are already in place. For even greater protection, a new first-of-its-kind technology called AIGISRx® Antibacterial Envelope is being used with traditional infection prevention methods in an effort to further reduce surgical site infection risk for patients.
